Literature DB >> 1812892

Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell-mediated lesions.

H Carlsten1, N Nilsson, R Jonsson, A Tarkowski.   

Abstract

Oestrogen is known to accelerate glomerulonephritis and autoantibody production in human and murine systemic lupus erythematosus (SLE). In this study we demonstrate that treatment of castrated autoimmune MRL +/+ mice with physiological doses of oestrogen results in enhanced immunoglobulin and autoantibody production as well as increased deposition of IgG in renal glomeruli. Accelerated development of glomerulonephritis was also evident from the increase of albuminuria. Interestingly, in contrast to these deteriorative effects of oestrogen on immune complex-mediated disease we now show that the lymphocytic infiltrations in the submandibular glands and perivascular lesions in the kidneys were significantly diminished after exposure to oestrogen. This remarkable impact of physiological oestrogen levels on the outcome of SLE in MRL +/+ mice is postulated to be the result of a differential effect on T and B cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812892     DOI: 10.1016/0896-8411(91)90048-h

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice.

Authors:  H Carlsten; M Verdrengh; M Taube
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

2.  Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

Authors:  Giuseppina Caligiuri; Mats Rudling; Véronique Ollivier; Marie-Paule Jacob; Jean-Baptiste Michel; Göran K Hansson; Antonino Nicoletti
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

Review 3.  The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Authors:  Maria Gulinello; Chaim Putterman
Journal:  J Biomed Biotechnol       Date:  2011-02-10

Review 4.  Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Adriana Rojas-Villarraga; July-Vianneth Torres-Gonzalez; Ángela-María Ruiz-Sternberg
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

5.  Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-lpr associated rheumatic conditions.

Authors:  L G Ratkay; D Zhang; J Tonzetich; J G Levy; J D Waterfield
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.